<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26728564</article-id>
<article-id pub-id-type="pmc">4935661</article-id>
<article-id pub-id-type="doi">10.1038/mp.2015.203</article-id>
<article-id pub-id-type="manuscript">NIHMS736995</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Early postnatal GABA<sub>A</sub> receptor modulation reverses deficits in neuronal maturation in a conditional neurodevelopmental mouse model of DISC1</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Saito</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taniguchi</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rannals</surname>
<given-names>Matthew D.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Merfeld</surname>
<given-names>Emily B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ballinger</surname>
<given-names>Michael D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koga</surname>
<given-names>Minori</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohtani</surname>
<given-names>Yoshikazu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gurley</surname>
<given-names>David A.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sedlak</surname>
<given-names>Thomas W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cross</surname>
<given-names>Alan</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moss</surname>
<given-names>Stephen J.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brandon</surname>
<given-names>Nicholas J.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maher</surname>
<given-names>Brady J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamiya</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA</aff>
<aff id="A2"><label>2</label>Department of Biological Psychiatry and Neuroscience, Dokkyo Medical University School of Medicine, Tochigi, Japan</aff>
<aff id="A3"><label>3</label>Basic Sciences Division, Lieber Institute for Brain Development, Baltimore, MD, USA</aff>
<aff id="A4"><label>4</label>Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd, Kanagawa, Japan</aff>
<aff id="A5"><label>5</label>Neuroscience iMED, AstraZeneca, Cambridge, MA, USA</aff>
<aff id="A6"><label>6</label>Department of Neuroscience, Tufts University School of Medicine, Boston, MA, USA</aff>
<aff id="A7"><label>7</label>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK</aff>
<author-notes>
<corresp id="cor1">Correspondence: Dr. A Kamiya, Department of Psychiatry, Johns Hopkins University, 600 N Wolfe Street, Meyer 3-146, Baltimore MD, 21287 USA. <email>akamiya1@jhmi.edu</email></corresp>
<fn fn-type="equal" id="FN1">
<label>8</label>
<p id="P1">These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>05</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<issue>10</issue>
<fpage>1449</fpage>
<lpage>1459</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2015.203-->
<permissions>
<license>
<license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms" xlink:type="simple">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
</license>
</permissions>
<abstract>
<p id="P2">Exploring drug targets based on disease-associated molecular mechanisms during development is crucial for the generation of novel prevention and treatment strategies for neurodevelopmental psychiatric conditions. We report that prefrontal cortex-specific postnatal knockdown of DISC1 via <italic>in utero</italic> electroporation combined with an inducible knockdown expression system drives deficits in synaptic GABA<sub>A</sub> function and dendritic development in pyramidal neurons, as well as abnormalities in sensorimotor gating, albeit without profound memory deficits. We show for the first time that DISC1 is specifically involved in regulating cell surface expression of α2 subunit-containing GABA<sub>A</sub> receptors in immature developing neurons, but not after full maturation. Notably, pharmacological intervention with α2/3 subtype-selective GABA<sub>A</sub> receptor positive allosteric modulators during the early postnatal period ameliorates dendritic deficits and behavioral abnormalities induced by knockdown of DISC1. These findings highlight a critical role of DISC1-mediated disruption of postnatal GABA signaling in aberrant prefrontal cortex maturation and function.</p>
</abstract>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>INTRODUCTION</title>
<p id="P3">γ-aminobutyric acid type A (GABA<sub>A</sub>) receptors are responsible for the majority of fast synaptic inhibition in the mature central nervous system.<sup><xref ref-type="bibr" rid="R1">1</xref></sup> During pre and early postnatal periods, GABA exerts a depolarizing and excitatory action, regulating multiple processes of neuronal maturation, including dendritic development.<sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R4">4</xref></sup> Notably, dendritic abnormalities and deficits in GABA signaling, including alteration of GABA<sub>A</sub> receptors have been implicated in multiple neurodevelopmental psychiatric disorders, such as autism spectrum disorder, epilepsy, and schizophrenia.<sup><xref ref-type="bibr" rid="R5">5</xref>–<xref ref-type="bibr" rid="R7">7</xref></sup> Accordingly, developmental GABA<sub>A</sub> receptor-mediated signaling is a unique molecular target to explore novel pharmacological treatment for these devastating conditions.</p>
<p id="P4">Many pharmacological agents targeting GABA<sub>A</sub> receptors are clinically available.<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup> Most prominently, benzodiazepines have diverse therapeutic actions by enhancing GABA<sub>A</sub> receptor channel functions.<sup><xref ref-type="bibr" rid="R8">8</xref></sup> Nonetheless, due to their serious adverse effects including sedation, cognitive impairment, and potential for addiction/abuse, development of new positive modulators of GABA<sub>A</sub> receptors with lesser side effects is awaited.<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup> Many of these aversive effects are most likely due to activation of α1 subunit-containing GABA<sub>A</sub> receptor,<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R9">9</xref></sup> leading researchers in academia and pharmaceutical companies to explore subtype-selective compounds without activity at α1 subunit-containing GABA<sub>A</sub> receptors.<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R8">8</xref></sup> Although a number of subtype-selective GABA<sub>A</sub> receptor compounds have been tested in patients with neuropsychiatric conditions and animal models in adults,<sup><xref ref-type="bibr" rid="R8">8</xref>,<xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup> their action during earlier developmental phases has been poorly investigated.</p>
<p id="P5">In the present study, we explore the effect of postnatal intervention of subtype-selective positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors on developmental deficits caused by knockdown of Disrupted-in-Schizophrenia-1 (DISC1), a genetic risk factor for major mental disorders.<sup><xref ref-type="bibr" rid="R13">13</xref></sup> DISC1 is involved in multiple cellular processes in the developing cerebral cortex.<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup> A functional interaction of DISC1 and NKCC1, a cation-chloride cotransporter which plays a role in excitatory GABA function in hippocampal neurogenesis, has been demonstrated.<sup><xref ref-type="bibr" rid="R16">16</xref></sup> In order to explore the specific role of DISC1 for developmental GABA<sub>A</sub> receptor-mediated signaling in the prefrontal cortex (PFC) during postnatal periods, we have developed a modified conditional knockdown method by using <italic>in utero</italic> electoroporation. This system allows us to suppress DISC1 expression, specifically in pyramidal neurons in the PFC during postnatal periods. This technique is an alternative method to genetically engineered animals, since region-specific genetic deletion is currently impractical.<sup><xref ref-type="bibr" rid="R17">17</xref>–<xref ref-type="bibr" rid="R19">19</xref></sup> Our data demonstrates that postnatal knockdown of DISC1 impairs developmental GABA<sub>A</sub> receptor-mediated signaling, which can be reversed by subtype-selective positive allosteric small molecule modulators of GABA<sub>A</sub> receptors during the early postnatal period.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec id="S3">
<title><italic>In utero</italic> electroporation with a new electrode with a three-electrode configuration</title>
<p id="P6"><italic>In utero</italic> electroporation targeting the prefrontal cortex (PFC) region was performed by our published protocol with some modifications.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> Pregnant C57/BL6 mice (Charles River) were anesthetized at embryonic day 14.5 (E14.5) by intraperitoneal administration of a mixed solution of Ketamine HCl (100 mg/kg), Xylazine HCl (7.5 mg/kg), and Buprenorphine HCl (0.05 mg/kg). After the uterine horn was exposed by laparotomy, inducible shRNA to DISC1 (2 µg/µl) and CALNL-GFP (1 µg/µl) together with CAG-ER<sup>T2</sup>CreER<sup>T2</sup> (1 µg/µl) (molar ratio, approximately 3:1:1) were injected into the bilateral ventricles with a glass micropipette made from a microcapillary tube (GD-1; Narishige). The embryo’s head in the uterus was held between the custom-made electrode, consisting of one positive and two negative pole disc-type electrodes (Nepagene). Electrode pulses (33V; 50 ms) were charged four times at intervals of 950 ms with an electroporator (CUY21EDIT; Nepagene). After electroporation, the uterine horn was replaced in the abdominal cavity to allow the embryos to continue to develop. Brains extracted from DISC1 knockdown and control animals were assessed to confirm GFP expression in proper PFC regions after behavioral characterization. All experiments were performed in accordance with the institutional guidelines for animal experiments.</p>
</sec>
<sec id="S4">
<title>Dendrite analysis</title>
<p id="P7">Dendrites of GFP-positive pyramidal neurons in layer II/III in medial PFC at postnatal day 7 (P7) were analyzed morphologically, according to modifications of previously published protocols.<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup> Z stacks of images were collected with a confocal microscope (LSM 510 Meta, Zeiss). Images of cells are taken using the 40 × oil-immersion objective lens as Z-series of images, averaged four times, taken at 0.8-µm intervals, 1024 × 1024 pixel resolution at a scan speed of 7 sec per section. Acquisition parameters were kept the same for all scans. Images were reconstructed by compressing the Z stacks, and then analyzed by using NeuronJ, plug-in software for ImageJ (<ext-link ext-link-type="uri" xlink:href="http://www.imagescience.org/meijering/software/neuronj/">http://www.imagescience.org/meijering/software/neuronj/</ext-link>) to trace primary, secondary, and tertiary branches of both apical and basal dendrites, and the number of dendrites per each category was calculated. In order to trace dendrites in a single GFP-positive neuron, the GFP-positive dendrites originating from other adjacent GFP-positive neurons were excluded based on observation of uncompressed z-scan images. In each condition, 10 neurons from independent brain slices were analyzed in a blinded manner. For quantification of dendritic complexity in pharmacological <italic>in vivo</italic> rescue experiments, a region of interest (ROI) was randomly selected (800 µm wide × 400 µm high) in layers I–III of medial PFC where GFP-positive cells were located. A z-series of 10 images were collected at 6.02-µm depth intervals with a confocal microscope (LSM710NLO-Meta, Zeiss). Acquisition parameters were kept the same for all images. Intensity of the GFP signal in the whole area and cell bodies in the ROI was measured from three images for each brain (total 10 brain sections for vehicle-treated mice and 10 brain sections from AZD7325-treated mice) by ImageJ software. The intensity ratio of GFP fluorescence of the processes (i.e., GFP signal in cell bodies subtracted from that in the whole area) to GFP fluorescence in the whole area was analyzed. Dendritic structure in cortical neurons at 7 DIV was analyzed by the previously published method with some modifications.<sup><xref ref-type="bibr" rid="R22">22</xref></sup> The images of GFP-positive neurons were acquired with a florescence microscope (LSM510 Meta, Zeiss) in a blinded manner. We analyzed only neurons with typical morphological characteristics of pyramidal neurons (single axon and multiple dendrites) by excluding neurons which have atypical morphological characteristics, such as multiple axons or atypical neuronal processes. The total length of dendrites and dendrite branch number were determined by using NeuronJ, plug-in software for ImageJ. Dendritic complexity was analyzed by using sholl analysis. The number of dendrites that crossed a series of concentric circles at 40-µm intervals from the soma was counted.</p>
</sec>
<sec id="S5">
<title>Treatment with GABA<sub>A</sub> positive allosteric modulator compounds</title>
<p id="P8">For <italic>in vitro</italic> assay, cortical neuron cultures expressing pSuper shRNA were treated daily with AZD7325 or AZD6280 (0.1 µM final concentration) for 7 days. To assess their effect on dendritic development <italic>in vivo</italic>, AZD7325 (10 µmol/kg body weight) with 40% (2-hydroxypropyl)-β-cyclodextrin or vehicle were injected intraperitoneally into postnatal DISC1 suppression mice for 1 week starting at postnatal day 4 (P4). Their pharmacological effects on dendritic structures and behavioral phenotypes were then assessed at P14 and 3 months old, respectively.</p>
<p id="P9">Details on the other experiments are provided in <xref ref-type="supplementary-material" rid="SD1">Supplementary Materials and Methods</xref>.</p>
</sec>
</sec>
<sec id="S6" sec-type="results">
<title>RESULTS</title>
<sec id="S7">
<title>DISC1 is involved in cell surface expression of GABA<sub>A</sub> receptors in developing neurons, but not in mature neurons</title>
<p id="P10">GABA<sub>A</sub> receptors are heteropentameric ligand-gated ion channels, which are mainly composed of two α, two β, and one γ subunits in the brain.<sup><xref ref-type="bibr" rid="R23">23</xref></sup> We first examined whether knockdown of DISC1 induced by lentivirus-based shRNA affects total and cell surface expression of α, β, and γ subunits of GABA<sub>A</sub> receptors in developing cultured cortical neurons. The knockdown effect of lentivirus-based shRNA to DISC1 on endogenous DISC1 was confirmed in developing cortical neurons (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 1</xref>). It is noted that we have previously confirmed knockdown effect of the same lentivirus-based shRNA to DISC1 on endogenous DISC1 in mature neurons.<sup><xref ref-type="bibr" rid="R24">24</xref></sup> Knockdown of DISC1 reduced cell surface expression of α2, β2, β3, and γ2 subunits, but not α1, α3, and α5 subunits, in developing cortical neurons at 7 days <italic>in vitro</italic> (7 DIV), whereas there were no changes in their total expression under these conditions (<xref ref-type="fig" rid="F1">Figure 1a</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 2</xref>). This was reversed by co-expressing RNAi-resistant wild-type DISC1 (<xref ref-type="fig" rid="F1">Figure 1a</xref>). Decreased cell surface expression of these GABA<sub>A</sub> receptor subunits was also confirmed in the developing pyramidal neurons by immunocytochemical staining (<xref ref-type="fig" rid="F1">Figure 1b</xref>). Neither total nor cell surface expression of the cation-chloride cotransporters, NKCC1 and KCC2, which are two major determinants for the excitatory and inhibitory neuronal response to GABA,<sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R25">25</xref></sup> were changed (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 2</xref>). Notably, when DISC1 expression was suppressed in mature cortical neurons at 30 DIV, no difference in total or cell surface expression of these GABA<sub>A</sub> receptor subunits was observed between DISC1 knockdown and control neurons (<xref ref-type="fig" rid="F1">Figure 1c</xref>). These results suggest that suppression of DISC1 expression specifically impairs cell surface expression of α2 subunit-containing GABA<sub>A</sub> receptors during early developmental periods.</p>
<p id="P11">To monitor whether DISC1 is involved in regulation of intracellular calcium concentration via GABA signaling, calcium imaging experiments were conducted in developing cortical neuron cultures expressing the genetically-encoded calcium indicator GCaMP3 together with shRNA to DISC1 or control scrambled shRNA, which carry a scarlet protein (<xref ref-type="fig" rid="F1">Figure 1d</xref>). Consistent with previous studies, bath application of GABA evoked increases of intracellular calcium in neurons expressing control shRNA at 7 DIV,<sup><xref ref-type="bibr" rid="R26">26</xref></sup> whereas knockdown of DISC1 diminished the effect of GABA administration on calcium influx (<xref ref-type="fig" rid="F1">Figure 1e</xref>). We confirmed that GABA-induced increase of intracellular calcium was mediated by GABA<sub>A</sub> receptor, as treatment with bicuculline, a GABA<sub>A</sub> receptor antagonist, blocks the effect (<xref ref-type="fig" rid="F1">Figure 1e</xref>).</p>
</sec>
<sec id="S8">
<title>Postnatal suppression of DISC1 expression by selective targeting of pyramidal neurons disrupts dendritic development in the PFC</title>
<p id="P12">In order to investigate the effect of DISC1 in the PFC, specifically in the postnatal period, we utilized <italic>in utero</italic> electroporation with a previously developed Cre/loxP-mediated inducible gene expression system (<xref ref-type="fig" rid="F2">Figure 2a and b</xref>)<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. With this system, a stop codon flanked by two LoxP sites downstream from the CAG promoter is contained in microRNA30 (mir30)-based short hairpin RNA (shRNA) and overexpression plasmids. Cre recombinase fused to the mutated estrogen receptor is expressed under the control of the CAG promoter (CAG-ER<sup>T2</sup>CreER<sup>T2</sup>), in which Cre is only active in the presence of 4-hydroxytamoxifen (4-OHT). We designed specific conditional shRNAs to DISC1 with independent target sequences, containing the sequences of which knockdown effects on DISC1 expression were previously characterized by conventional shRNAs and lentivirus-mediated RNAi approaches.<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R30">30</xref></sup> We also made an inducible plasmid expressing HA-tagged RNAi-resistant wild-type mouse DISC1, in which four silent mutations are contained in the target sequence of shRNA to DISC1 (CALNL-HA-DISC1<sup>R</sup>).<sup><xref ref-type="bibr" rid="R28">28</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup> We confirmed the inducible knockdown effect of DISC1 on exogenously overexpressed wild-type mouse DISC1 and overexpression of RNAi-resistant wild-type mouse DISC1 in HEK 293 cells treated with 4-OHT (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 3</xref>), whose efficacies are comparable to lentivirus-based shRNA to DISC1 (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 1</xref>). To manipulate targeted gene expression in the bilateral PFC, we have developed a modified <italic>in utero</italic> electroporation method with a new electrode, which overcomes inefficiencies of our previous method which required a double electroporation step.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> The new electrode has a three-pole configuration, composed of one positive pole and two negative poles, which was confirmed to target the bilateral PFC more precisely (<xref ref-type="fig" rid="F2">Figure 2c</xref>). In the developing cerebral cortex, pyramidal neurons originate from the ventricular zone and migrate radially into the cerebral cortex.<sup><xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup> Given that interneurons migrate tangentially from a ganglionic eminence<sup><xref ref-type="bibr" rid="R31">31</xref></sup> and glial cells are produced at late embryonic and early postnatal days,<sup><xref ref-type="bibr" rid="R32">32</xref></sup> the plasmid constructs introduced by <italic>in utero</italic> electroporation in the mid-embryonic periods are exclusively integrated into a lineage of pyramidal neurons as previously shown.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> The efficacy of the modified technique with the new electrode was tested by a single electroporation of the inducible overexpression plasmid of green fluorescent protein (CALNL-GFP) and CAG-ER<sup>T2</sup>CreER<sup>T2</sup> into PFC at embryonic day 14.5 (E14.5), followed by intraperitoneal injection of 4-OHT at postnatal day 2 (P2). We confirmed that GFP was extensively expressed in the bilateral PFC areas, simultaneously, at P7 (<xref ref-type="fig" rid="F2">Figure 2c</xref>).</p>
<p id="P13">We adapted this device to test the <italic>in vivo</italic> knockdown effect of DISC1 during the postnatal period by use of the Cre/loxP-mediated expression system. Inducible shRNA to DISC1 (DISC1 RNAi) or scrambled control shRNA (Control RNAi), together with CALNL-GFP and CAG-ER<sup>T2</sup>CreER<sup>T2</sup>, were electroporated into the developing PFC at E14.5, and pups were given 4-OHT at P2, when early postnatal period dendrite growth occurs. We have previously reported that <italic>in utero</italic> electroporation can be used to specifically target approximately 20 % of pyramidal neurons in layers II/III of the PFC.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> Consistently, the present study found that GFP-positive cells are confined to CaMKII-positive pyramidal neurons, approximately 20% of which are GFP-positive in layers II/III of the medial PFC (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 4</xref>). Knockdown of endogenous DISC1 in pyramidal neurons in the medial PFC was confirmed at P7 via immunohistochemistry, utilizing a previously characterized DISC1 antibody (<xref ref-type="fig" rid="F2">Figure 2d</xref>).<sup><xref ref-type="bibr" rid="R33">33</xref></sup></p>
<p id="P14">Dendritic structure is regulated by multiple mechanisms, including GABA<sub>A</sub> receptor-mediated signaling in early postnatal periods,<sup><xref ref-type="bibr" rid="R2">2</xref>,<xref ref-type="bibr" rid="R3">3</xref></sup> and is a critical component for neuronal information processing through synaptic integration.<sup><xref ref-type="bibr" rid="R34">34</xref></sup> To evaluate the importance of DISC1 in dendritic growth specifically in post-migratory neurons, we monitored the effects of postnatal suppression of DISC1 expression on dendritic development in the medial PFC by use of the aforementioned Cre/loxP-mediated expression system via <italic>in utero</italic> electroporation. When observed at P7 in the medial PFC, a period of robust dendritic growth, numbers of apical and basal dendrites, as well as secondary branches of basal dendrites and tertiary branches of both apical and basal dendrites were reduced by the postnatal knockdown of DISC1, without deficits in radial neuronal migration (<xref ref-type="fig" rid="F2">Figure 2e, f</xref>, and <xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 5</xref>). The reduction in number of dendrites and branches was seen in a knockdown effect-dependent manner and reversed by inducible co-expression of RNAi-resistant wild-type DISC1 (<xref ref-type="fig" rid="F2">Figure 2e and f</xref>), suggesting that the observed phenotype is specifically due to knockdown of DISC1. We previously reported that conventional knockdown of DISC1 in the medial PFC starting at prenatal periods results in reduction of immunoreactivity of paravalbumin (PV), a marker of the fast spiking GABAergic interneurons.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> When DISC1 expression was suppressed at the postnatal periods by inducible knockdown approaches, we observed no significant change in the number of PV-positive neurons in the medial PFC at young adulthood (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 6</xref>), indicating that knockdown of DISC1 in the postnatal periods is not sufficient for impairment of PV-positive neuron maturation.</p>
</sec>
<sec id="S9">
<title>Postnatal suppression of DISC1 expression in the PFC impairs developmental synaptic GABA function</title>
<p id="P15">In order to examine the importance of postnatal expression of DISC1 for synaptic expression of α2 subunit-containing GABA<sub>A</sub> receptors under <italic>in vivo</italic> conditions, we analyzed cellular distribution of GABA<sub>A</sub> receptors and gephyrin, a GABA synaptic scaffold protein in the medial PFC of mice with postnatal suppression of DISC1 expression. Although inducible knockdown of DISC1 does not affect the number of gephyrin puncta and colocalization of gephyrin and vesicular GABA transporter (vGAT), a presynaptic marker for GABAergic synapses, a reduction in colocalization of gephyrin and α2 subunit of GABA<sub>A</sub> receptors was observed in the dendrites of developing pyramidal neurons (<xref ref-type="fig" rid="F3">Figure 3a and b</xref>). These results indicate that knockdown of DISC1 reduces expression of α2 subunit in the GABAergic synapses in a cell-autonomous manner.</p>
<p id="P16">Postnatal suppression of DISC1 expression may affect synaptic GABA<sub>A</sub> receptor function. To test this idea, synaptic GABA<sub>A</sub> receptor function was measured by whole-cell electrophysiology in postnatal PFC brain slices of inducible DISC1 knockdown mice and control mice with inducible scrambled control shRNA. Consistent with immunohistochemical data (<xref ref-type="fig" rid="F3">Figure 3a and b</xref>), we found significant reductions in the amplitude of GABA-mediated miniature postsynaptic currents (GABA-mediated mPSCs) in neurons with postnatal suppression of DISC1 expression under pharmacological blockade of NMDA receptors (100 µM DL-AP5), AMPA receptors (10 µM NBQX), and sodium channels (1 µM TTX), whereas no difference was observed in the frequency of GABA-mediated mPSCs between both groups of mice (<xref ref-type="fig" rid="F3">Figure 3c and d</xref>).</p>
</sec>
<sec id="S10">
<title>Postnatal suppression of DISC1 expression in the PFC impairs sensorimotor gating, albeit without profound memory deficits, in young adulthood</title>
<p id="P17">We next examined whether postnatal knockdown of DISC1 in the PFC results in long lasting behavioral alterations. Given that changes in body weight may reflect nonspecific developmental abnormalities and resultant behaviors, we examined differences in body weight between inducible DISC1 knockdown mice and control mice with inducible scrambled control shRNA at 3 months of age, but observed no difference (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 7</xref>). Animals were then evaluated in the open field test and elevated plus maze test to measure locomotor activity and anxiety-related behavior, which might confound assessment of cognitive behaviors. There was no difference in either test between both groups of mice (<xref ref-type="fig" rid="F4">Figure 4a and b</xref>). Our previous study established that knockdown of DISC1 in the PFC starting from the embryonic period resulted in deficits in cognitive function and sensory information processing, assessed by the novel object recognition test (NORT) and prepulse inhibition test (PPI).<sup><xref ref-type="bibr" rid="R20">20</xref></sup> To examine whether postnatal suppression of DISC1 expression is sufficient to elicit these behavioral abnormalities, NORT and PPI were performed in 3-month-old animals with inducible knockdown of DISC1. In the NORT, no difference was observed between inducible DISC1 knockdown mice and controls for total exploration time and exploratory preference of the novel object and its location, suggesting that postnatal suppression of DISC1 expression in the PFC has no major impact on object and spatial recognition memory (<xref ref-type="fig" rid="F4">Figure 4c</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 8</xref>). Of note, we found a significant increase in the baseline of acoustic startle response as well as a reduction in PPI with prepulses of 74 dB, 78 dB, and 82 dB in the inducible DISC1 knockdown mice (<xref ref-type="fig" rid="F4">Figure 4d and e</xref>), indicating that postnatal expression of DISC1 in the PFC is required for normal sensorimotor gating. To examine the neuronal circuit mechanisms underlying these behavioral alterations induced by knockdown of DISC1, expression of c-Fos, an immediate early gene, was evaluated in several brain regions where we demonstrated existence of direct projections from GFP-positive pyramidal neurons in the PFC after the mice were given the pulse in PPI experiments (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 9a</xref>). These brain areas include the nucleus accumbens core and shell as well as the basolateral amygdala, which are implicated in both the acoustic startle response and PPI.<sup><xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref></sup> We found that induction of c-Fos in the basolateral amygdala, but not in the nucleus accumbens core and shell, was impaired by postnatal knockdown of DISC1 (<xref ref-type="fig" rid="F4">Figure 4f</xref>). Importantly double-labeling experiments revealed that observed induction of c-Fos elevation in the basolateral amygdala is occurring predominantly in GAD67-positive GABAergic neurons (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 9b</xref>).</p>
</sec>
<sec id="S11">
<title>Subtype-selective positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors reverse dendritic abnormalities induced by suppression of DISC1 in developing cortical neurons</title>
<p id="P18">Results thus far indicate that postnatal knockdown of DISC1 causes a reduction in cell surface expression of α2 subunit-containing GABA<sub>A</sub> receptors, impaired postsynaptic GABA<sub>A</sub> receptor signaling, dendritic abnormalities in developing pyramidal neurons, and behavioral alterations including excessive startle response and deficits in PPI. We therefore investigated whether pharmacological activation of GABA<sub>A</sub> receptors might overcome these abnormalities due to suppression of DISC1 expression. A variety of subtype-selective compounds of GABA<sub>A</sub> receptors have recently been synthesized.<sup><xref ref-type="bibr" rid="R8">8</xref></sup> We tested the potential of two novel subtype-selective positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors (AZD7325 and AZD6280) (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 10</xref>) to overcome dendritic alterations induced by knockdown of DISC1 in developing cortical neuron cultures. These compounds were previously shown to have modest efficacy on α2/3-containing GABA<sub>A</sub> receptors and low efficacy on α1 or α5 containing subtypes.<sup><xref ref-type="bibr" rid="R38">38</xref></sup> These observations were confirmed by electrophysiological characterization in Xenopus oocytes expressing α1, α2, α3, or α5-containing GABA<sub>A</sub> receptors (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 11</xref>). Application of either AZD7325 or AZD6280 rescued dendritic abnormalities induced by knockdown of DISC1, including both numbers of branches as well as total dendritic length and complexity; this effect is comparable to that of overexpression of RNAi-resistant wild-type DISC1 (<xref ref-type="fig" rid="F5">Figure 5a, b</xref> and <xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 12</xref>). We also found that treatment with AZD7325 does not affect impaired cell surface expression of α2 subunit induced by knockdown of DISC1 (<xref ref-type="supplementary-material" rid="SD2">Supplementary Figure 13</xref>). We then examined whether transient administration of AZD7325 during the early postnatal period ameliorates observed neuronal and behavioral deficits in inducible DISC1 suppression mice. AZD7325 (10 µmol/kg body weight) and vehicle were administered intraperitoneally daily for 1 week starting from P4. Dendritic quantity in the mPFC was measured at P14 by comparing fluorescence intensity. We observed that transient pharmacological early intervention with AZD7325 reversed dendritic deficits caused by postnatal DISC1 suppression (<xref ref-type="fig" rid="F5">Figure 5c</xref>). The effect of treatment with AZD7325 on abnormalities in acoustic startle response and PPI was then assessed in 3-month-old animals. In addition to normalization of the elevated startle response, a reduction in PPI with prepulses of 74 dB was rescued by early postnatal treatment with AZD7325 (<xref ref-type="fig" rid="F5">Figure 5d and e</xref>).</p>
</sec>
</sec>
<sec id="S12" sec-type="discussion">
<title>DISCUSSION</title>
<p id="P19">Our data indicate that DISC1 is involved in regulating cell surface expression of α2 subunit-containing GABA<sub>A</sub> receptors and postsynaptic GABA<sub>A</sub> receptor signaling during early postnatal periods. Given that knockdown of DISC1 has no effect on total protein expression levels of GABA<sub>A</sub> receptors, reduction of cell surface expression of GABA<sub>A</sub> receptors is unlikely to result from slow maturation of these neurons caused by knockdown of DISC1. Although molecular mechanisms determining how DISC1 is involved in cell surface expression of α2 subunit-containing GABA<sub>A</sub> receptors in developing neurons are still unclear, it is worth noting that DISC1 has been reported to bind to the kinesin family member 5 that regulates GABA<sub>A</sub> receptor intracellular transport.<sup><xref ref-type="bibr" rid="R39">39</xref>,<xref ref-type="bibr" rid="R40">40</xref></sup> Thus DISC1 may participate in the targeting of these receptors to the cell surface or specific neuronal compartments. Multiple DISC1-associated signaling pathways are involved in dendritic growth.<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>,<xref ref-type="bibr" rid="R41">41</xref></sup> However, our data demonstrate that pharmacological potentiation of GABA<sub>A</sub> receptor-mediated signaling rescued dendritic abnormalities caused by knockdown of DISC1, suggesting that DISC1 may be involved in developmental control of dendrite growth through modulation of GABA signaling. Of note, the effect of DISC1 on cell surface expression of GABA<sub>A</sub> receptors is specific to the developmental phase and treatment with subtype-selective positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors during the early postnatal period alleviated dendritic and behavioral abnormalities, though it remains an open question whether the observed abnormalities induced by knockdown of DISC1 could also be rescued by other subtype-selective modulators.</p>
<p id="P20">Based on our results, we assume that reduced GABAergic inhibition in the basolateral amygdala may contribute to dysfunction in medial PFC-basolateral amygdala circuits that underlies the observed behavioral changes. Changes in the activity of circuits connecting these brain regions may represent a potential mechanism that contributes to the enhanced acoustic startle response and impaired sensorimotor gating caused by postnatal knockdown of DISC1. This hypothesis is supported by previous findings that pharmacological blockade of GABA<sub>A</sub> receptors in the basolateral amygdala leads to an enhanced startle response and deficits in PPI.<sup><xref ref-type="bibr" rid="R42">42</xref></sup> We have previously demonstrated that knockdown of DISC1 beginning at prenatal periods leads to abnormalities in dopaminergic circuit maturation.<sup><xref ref-type="bibr" rid="R20">20</xref></sup> Given that mesocortical and mesolimbic dopaminergic projections are involved in regulating sensorimotor gating,<sup><xref ref-type="bibr" rid="R35">35</xref></sup> it would be interesting to elucidate how postnatal knockdown of DISC1 in the PFC affects dopaminergic circuits, whose disturbance may also underlie excess acoustic startle response and PPI deficits observed in our mouse models.</p>
<p id="P21">Pharmacological targeting of excitatory GABA signaling during early development has recently started to be tested. Tyzio <italic>et al</italic>. have reported that maternal treatment with bumetanide, a NKCC1 blocker, ameliorates autism-associated electrophysiological and behavioral characteristics in animal models with <italic>in utero</italic> exposure to valprorate and mouse model carrying the fragile X mutation.<sup><xref ref-type="bibr" rid="R43">43</xref></sup> In contrast, perinatal treatment with bumetanide has detrimental effects on dendritic maturation and behaviors.<sup><xref ref-type="bibr" rid="R44">44</xref></sup> The discrepancy between these studies cautions us that dose and timing of pharmacological modulators to alter developmental GABA signaling is critical to obtain beneficial effects on disease conditions.</p>
<p id="P22">To the best of our knowledge, this is the first study demonstrating the utility of a conditional knockdown system with <italic>in utero</italic> electroporation for gene targeting in a spatial and temporal manner. This approach allowed us to segregate a role for DISC1 in dendritic development, independent from the secondary effects of DISC1 on dendrites caused by disturbed cell proliferation and neuronal migration. DISC1 is involved in diverse cellular processes in the developing cerebral cortex.<sup><xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref></sup> These include cell proliferation, neuronal migration, and dendrite growth, which have been demonstrated in various rodent models.<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R30">30</xref>,<xref ref-type="bibr" rid="R45">45</xref>–<xref ref-type="bibr" rid="R52">52</xref></sup> Nonetheless, how DISC1-mediated pathways in specific developmental periods are involved in these phenotypes is unclear. Here we report that suppression of DISC1 expression in the PFC in the postnatal period impaired developmental synaptic GABA<sub>A</sub> receptor function and was sufficient to evoke deficits in dendritic growth and sensorimotor gating in young adulthood. Similarly, indirect disruption of early GABA excitatory action caused by perinatal treatment with bumetanide, results in deficits in dendritic formation in cortical neurons and sensorimotor gating.<sup><xref ref-type="bibr" rid="R44">44</xref></sup></p>
<p id="P23">Although it is laboriously difficult to investigate effective therapeutic strategies to restore function due to a genetic predisposition during brain development in humans, our study provides proof-of-principle that pharmacological intervention during specific postnatal periods may be critical. Thus, mechanism-based pharmacological application during development is warranted to be tested in animal models.</p>
</sec>
<sec id="SM" sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>1</label>
<media id="d37e958" orientation="portrait" position="anchor" xlink:href="NIHMS736995-supplement-1.doc" xlink:type="simple"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>2</label>
<media id="d37e962" orientation="portrait" position="anchor" xlink:href="NIHMS736995-supplement-2.pdf" xlink:type="simple"></media>
</supplementary-material>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="COI-statement" id="FN2">
<p id="P24">
<bold>CONFLICT OF INTEREST</bold>
</p>
<p id="P25">A.C. and N.J.B. are full-time employees and shareholders in AstraZeneca. S.J.M serves as a consultant for SAGE therapeutics and AstraZeneca, relationships that are regulated by Tufts University.</p>
</fn>
</fn-group>
<ack id="S13">
<title>ACKNOWLEDGEMENTS</title>
<p id="P26">We thank Drs. Pamela Talalay and Keri Martinowich, as well as Ms. Nada Rendradjaja for critical reading of the manuscript. We thank Drs. Kozo Kaibuchi and Keisuke Kuroda for providing us with DISC1 antibodies and Dr. Miho Terunuma for advice on biotinylation assays. This work was supported by R01 MH-091230 (A.K.), P50 MH-094268 (A.K.), R21AT008547 (A.K.), K01 MH-086050 (B.J.M.), Brain &amp; Behavior Research Foundation (A.K.), and Brain Science Foundation (A.K.).</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritschy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Panzanelli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system</article-title>
<source/>Eur J Neurosci
          <year>2014</year>
<volume>39</volume>
<fpage>1845</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="pmid">24628861</pub-id>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Ari</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Excitatory actions of gaba during development: the nature of the nurture</article-title>
<source/>Nat Rev Neurosci
          <year>2002</year>
<volume>3</volume>
<fpage>728</fpage>
<lpage>739</lpage>
<pub-id pub-id-type="pmid">12209121</pub-id>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cancedda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fiumelli</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Poo</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<fpage>5224</fpage>
<lpage>5235</lpage>
<pub-id pub-id-type="pmid">17494709</pub-id>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Magueresse</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Monyer</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>GABAergic interneurons shape the functional maturation of the cortex</article-title>
<source/>Neuron
          <year>2013</year>
<volume>77</volume>
<fpage>388</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">23395369</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charych</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders</article-title>
<source/>Neuropharmacology
          <year>2009</year>
<volume>57</volume>
<fpage>481</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="pmid">19631671</pub-id>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cellot</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cherubini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>GABAergic signaling as therapeutic target for autism spectrum disorders</article-title>
<source/>Front Pediatr
          <year>2014</year>
<volume>2</volume>
<fpage>70</fpage>
<pub-id pub-id-type="pmid">25072038</pub-id>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoftman</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia</article-title>
<source/>Schizophr Bull
          <year>2011</year>
<volume>37</volume>
<fpage>493</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="pmid">21505116</pub-id>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudolph</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Knoflach</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes</article-title>
<source/>Nat Rev Drug Discov
          <year>2011</year>
<volume>10</volume>
<fpage>685</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="pmid">21799515</pub-id>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crestani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Mohler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rudolph</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Mechanism of action of the hypnotic zolpidem in vivo</article-title>
<source/>Br J Pharmacol
          <year>2000</year>
<volume>131</volume>
<fpage>1251</fpage>
<lpage>1254</lpage>
<pub-id pub-id-type="pmid">11090095</pub-id>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Scheuer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</name>
</person-group>
<article-title>Enhancement of inhibitory neurotransmission by GABAA receptors having alpha2,3-subunits ameliorates behavioral deficits in a mouse model of autism</article-title>
<source/>Neuron
          <year>2014</year>
<volume>81</volume>
<fpage>1282</fpage>
<lpage>1289</lpage>
<pub-id pub-id-type="pmid">24656250</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lewis</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Eklund</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia</article-title>
<source/>Am J Psychiatry
          <year>2008</year>
<volume>165</volume>
<fpage>1585</fpage>
<lpage>1593</lpage>
<pub-id pub-id-type="pmid">18923067</pub-id>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchanan</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Lieberman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Barch</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Csernansky</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>DC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia</article-title>
<source/>Biol Psychiatry
          <year>2011</year>
<volume>69</volume>
<fpage>442</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="pmid">21145041</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Wilson-Annan</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Christie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of two novel genes by a translocation co-segregating with schizophrenia</article-title>
<source/>Hum Mol Genet
          <year>2000</year>
<volume>9</volume>
<fpage>1415</fpage>
<lpage>1423</lpage>
<pub-id pub-id-type="pmid">10814723</pub-id>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Linking neurodevelopmental and synaptic theories of mental illness through DISC1</article-title>
<source/>Nat Rev Neurosci
          <year>2011</year>
<volume>12</volume>
<fpage>707</fpage>
<lpage>722</lpage>
<pub-id pub-id-type="pmid">22095064</pub-id>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sedlak</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Pletnikov</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders</article-title>
<source/>Front Psychiatry
          <year>2012</year>
<volume>3</volume>
<fpage>25</fpage>
<pub-id pub-id-type="pmid">22461775</pub-id>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia</article-title>
<source/>Cell
          <year>2012</year>
<volume>148</volume>
<fpage>1051</fpage>
<lpage>1064</lpage>
<pub-id pub-id-type="pmid">22385968</pub-id>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manent</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Paramasivam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>LoTurco</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Dcx reexpression reduces subcortical band heterotopia and seizure threshold in an animal model of neuronal migration disorder</article-title>
<source/>Nat Med
          <year>2009</year>
<volume>15</volume>
<fpage>84</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">19098909</pub-id>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LoTurco</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Manent</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Sidiqi</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>New and improved tools for in utero electroporation studies of developing cerebral cortex</article-title>
<source/>Cereb Cortex
          <year>2009</year>
<volume>19</volume>
<issue>Suppl 1</issue>
<fpage>i120</fpage>
<lpage>i125</lpage>
<pub-id pub-id-type="pmid">19395528</pub-id>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniguchi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Young-Pearse</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors</article-title>
<source/>Neuroscientist
          <year>2012</year>
<volume>18</volume>
<fpage>169</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">21551077</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niwa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Murai</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gruber</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits</article-title>
<source/>Neuron
          <year>2010</year>
<volume>65</volume>
<fpage>480</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="pmid">20188653</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Paterlini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pavlidis</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2006</year>
<volume>103</volume>
<fpage>16906</fpage>
<lpage>16911</lpage>
<pub-id pub-id-type="pmid">17077150</pub-id>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takemoto-Kimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ageta-Ishihara</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nonaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adachi-Morishima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mano</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of dendritogenesis via a lipid-raft-associated Ca2+/calmodulin-dependent protein kinase CLICK-III/CaMKIgamma</article-title>
<source/>Neuron
          <year>2007</year>
<volume>54</volume>
<fpage>755</fpage>
<lpage>770</lpage>
<pub-id pub-id-type="pmid">17553424</pub-id>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moss</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Smart</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Constructing inhibitory synapses</article-title>
<source/>Nat Rev Neurosci
          <year>2001</year>
<volume>2</volume>
<fpage>240</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="pmid">11283747</pub-id>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi-Takagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Takaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Graziane</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dunlop</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1</article-title>
<source/>Nat Neurosci
          <year>2010</year>
<volume>13</volume>
<fpage>327</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="pmid">20139976</pub-id>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cellot</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cherubini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Functional role of ambient GABA in refining neuronal circuits early in postnatal development</article-title>
<source/>Front Neural Circuits
          <year>2013</year>
<volume>7</volume>
<fpage>136</fpage>
<pub-id pub-id-type="pmid">23964205</pub-id>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porcher</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hatchett</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Longbottom</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>McAinch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sihra</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Moss</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positive feedback regulation between gamma-aminobutyric acid type A (GABA(A)) receptor signaling and brain-derived neurotrophic factor (BDNF) release in developing neurons</article-title>
<source/>J Biol Chem
          <year>2011</year>
<volume>286</volume>
<fpage>21667</fpage>
<lpage>21677</lpage>
<pub-id pub-id-type="pmid">21474450</pub-id>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cepko</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Controlled expression of transgenes introduced by in vivo electroporation</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2007</year>
<volume>104</volume>
<fpage>1027</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="pmid">17209010</pub-id>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishizuka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Kanki</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>FJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A DISC1-dependent switch from neuronal proliferation to migration in the developing cortex</article-title>
<source/>Nature
          <year>2011</year>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomoda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ozeki</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development</article-title>
<source/>Nat Cell Biol
          <year>2005</year>
<volume>7</volume>
<fpage>1167</fpage>
<lpage>1178</lpage>
<pub-id pub-id-type="pmid">16299498</pub-id>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kubo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tomita</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Uto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Migration defects by DISC1 knockdown in C57BL/6, 129X1/SvJ, and ICR strains via in utero gene transfer and virus-mediated RNAi</article-title>
<source/>Biochem Biophys Res Commun
          <year>2010</year>
<volume>400</volume>
<fpage>631</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="pmid">20807500</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Cell migration in the forebrain</article-title>
<source/>Annu Rev Neurosci
          <year>2003</year>
<volume>26</volume>
<fpage>441</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="pmid">12626695</pub-id>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauvageot</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Stiles</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms controlling cortical gliogenesis</article-title>
<source/>Curr Opin Neurobiol
          <year>2002</year>
<volume>12</volume>
<fpage>244</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="pmid">12049929</pub-id>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seshadri</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kamiya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yokota</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Prikulis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashi-Takagi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<fpage>5622</fpage>
<lpage>5627</lpage>
<pub-id pub-id-type="pmid">20212127</pub-id>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Calcium signaling and the control of dendritic development</article-title>
<source/>Neuron
          <year>2005</year>
<volume>46</volume>
<fpage>401</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">15882639</pub-id>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swerdlow</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Geyer</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Braff</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges</article-title>
<source/>Psychopharmacology (Berl)
          <year>2001</year>
<volume>156</volume>
<fpage>194</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="pmid">11549223</pub-id>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex</article-title>
<source/>J Neurosci
          <year>1997</year>
<volume>17</volume>
<fpage>6434</fpage>
<lpage>6446</lpage>
<pub-id pub-id-type="pmid">9236251</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The neurobiology of startle</article-title>
<source/>Prog Neurobiol
          <year>1999</year>
<volume>59</volume>
<fpage>107</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="pmid">10463792</pub-id>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alhambra</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Blake</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Damewood</surname>
<given-names>JR</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Daniels</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Development and SAR of functionally selective allosteric modulators of GABAA receptors</article-title>
<source/>Bioorg Med Chem
          <year>2011</year>
<volume>19</volume>
<fpage>2927</fpage>
<lpage>2938</lpage>
<pub-id pub-id-type="pmid">21498079</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Twelvetrees</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Arancibia-Carcamo</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>MacAskill</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Rostaing</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lumb</surname>
<given-names>MJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Delivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin</article-title>
<source/>Neuron
          <year>2010</year>
<volume>65</volume>
<fpage>53</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">20152113</pub-id>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shinoda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsuboi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Asaki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hikita</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1</article-title>
<source/>J Neurosci
          <year>2007</year>
<volume>27</volume>
<fpage>15</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">17202468</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porteous</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Millar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Brandon</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>DISC1 at 10: connecting psychiatric genetics and neuroscience</article-title>
<source/>Trends Mol Med
          <year>2011</year>
<volume>17</volume>
<fpage>699</fpage>
<lpage>706</lpage>
<pub-id pub-id-type="pmid">22015021</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fendt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schwienbacher</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Amygdaloid N-methyl-D-aspartate and gamma-aminobutyric acid(A) receptors regulate sensorimotor gating in a dopamine-dependent way in rats</article-title>
<source/>Neuroscience
          <year>2000</year>
<volume>98</volume>
<fpage>55</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="pmid">10858611</pub-id>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyzio</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nardou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Tsintsadze</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shahrokhi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Eftekhari</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring</article-title>
<source/>Science
          <year>2014</year>
<volume>343</volume>
<fpage>675</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="pmid">24503856</pub-id>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Kriegstein</surname>
<given-names>AR</given-names>
</name>
</person-group>
<article-title>Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits</article-title>
<source/>Cereb Cortex
          <year>2011</year>
<volume>21</volume>
<fpage>574</fpage>
<lpage>587</lpage>
<pub-id pub-id-type="pmid">20624842</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young-Pearse</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Suth</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Luth</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Sawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Selkoe</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>Biocemical and Functional Interaction of Disrupted-in-Schizophrenia 1 and Amyloid Precursor Protein Regulates Neuronal Migration during Mammalian Cortical Development</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<fpage>10431</fpage>
<lpage>10440</lpage>
<pub-id pub-id-type="pmid">20685985</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kvajo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McKellar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Arguello</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Drew</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>H</given-names>
</name>
<name>
<surname>MacDermott</surname>
<given-names>AB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<fpage>7076</fpage>
<lpage>7081</lpage>
<pub-id pub-id-type="pmid">18458327</pub-id>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pletnikov</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Ayhan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nikolskaia</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ovanesov</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2008</year>
<volume>13</volume>
<fpage>173</fpage>
<lpage>186</lpage>
<fpage>115</fpage>
<pub-id pub-id-type="pmid">17848917</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Fadel</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Preston-Maher</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cordes</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Clapcote</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disc1 point mutations in mice affect development of the cerebral cortex</article-title>
<source/>J Neurosci
          <year>2011</year>
<volume>31</volume>
<fpage>3197</fpage>
<lpage>3206</lpage>
<pub-id pub-id-type="pmid">21368031</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Faulkner</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Kitabatake</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain</article-title>
<source/>Cell
          <year>2007</year>
<volume>130</volume>
<fpage>1146</fpage>
<lpage>1158</lpage>
<pub-id pub-id-type="pmid">17825401</pub-id>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nakamoto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kuan</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<fpage>10893</fpage>
<lpage>10904</lpage>
<pub-id pub-id-type="pmid">18945897</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maher</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>LoTurco</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Disrupted-in-schizophrenia (DISC1) functions presynaptically at glutamatergic synapses</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e34053</fpage>
<pub-id pub-id-type="pmid">22479520</pub-id>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Madison</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Koehler</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Doud</surname>
<given-names>MK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling</article-title>
<source/>Cell
          <year>2009</year>
<volume>136</volume>
<fpage>1017</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="pmid">19303846</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p id="P27">Suppression of DISC1 expression impairs cell surface expression of GABA<sub>A</sub> receptor in developing neurons, but not in mature neurons. (<bold>a</bold>) Reduction of cell surface expression of GABA<sub>A</sub> receptor by knockdown of DISC1 (DISC1 RNAi) in developing cortical neurons at 7 days <italic>in vitro</italic> (7 DIV). Cell surface proteins were labeled by biotinylation, precipitated by avidin-conjugated beads, and immunoblotted for GABA<sub>A</sub> receptor α2, β2/3, and γ2 subunits. Cell surface expression of GABA<sub>A</sub> receptor α2, β2/3, and γ2 subunits (red arrowheads) was reduced by knockdown of DISC1 (left panels), but there was no change in their total expression (right panels). Reduction of their cell surface expression was reversed by co-expression of RNAi-resistant DISC1 (DISC1<sup>R</sup>). (<bold>b</bold>) Reduction of cell surface expression of GABA<sub>A</sub> receptors by immunocytochemistry with antibodies against α2, β3, and γ2 subunits (red traced by dotted white lines) under nonpermeant conditions in developing cortical neurons with knockdown of DISC1 (green) at 7 DIV. Blue, nucleus. Scale bar, 20 µm. (<bold>c</bold>) Knockdown of DISC1 has no effect on total or cell surface expression of GABA<sub>A</sub> receptors in mature cortical neurons at 30 DIV. TfR, transferrin receptor. (<bold>d</bold>) Impairment of GABA<sub>A</sub> receptor-dependent increase in [Ca<sup>2+</sup>] by knockdown of DISC1 in developing cortical neurons. Calcium imaging was assessed using the developing primary cortical neurons at 7 DIV transfected with GCaMP3 (green) as well as shRNAs to DISC1 (DISC1 RNAi) or scrambled controls (Control RNAi), which carry scarlet protein (red). Scale bar, 20 µm. (<bold>e</bold>) Bath application of GABA (50 µM) elicited increase in intracellular Ca<sup>2+</sup> concentration in neurons with control RNAi, whereas knockdown of DISC1 impaired Ca<sup>2+</sup> influx. Increase of calcium influx induced by GABA was prevented by treatment with bicuculline (10 µM). n = 10 neurons per condition. Bars represent averages of each group in three independent experiments (<bold>a, c</bold>). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001 determined by one-way ANOVA with posthoc Bonferroni test (<bold>a, e</bold>) and Student’s <italic>t</italic> test (<bold>c</bold>)</p>
</caption>
<graphic xlink:href="nihms736995f1"></graphic>
</fig>
<fig id="F2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p id="P28">Postnatal suppression of DISC1 expression by selective targeting of pyramidal neurons in the prefrontal cortex (PFC) impairs dendritic development. (<bold>a</bold>) Schematic representation showing gene targeting by using the Cre/loxP system via <italic>in utero</italic> electroporation. Cells expressing inducible plasmids (green) that have migrated to the proper cortical layer; red cells represent post-migratory neurons, in which inducible plasmids were activated by intraperitoneal injection of 4-hydroxytamoxifen (4-OHT) during the postnatal period. MZ, marginal zone; CP, cortical plate; IZ, intermediate zone; SVZ/VZ, subventricular zone/ventricular zone. IUE, <italic>in utero</italic> electroporation. (<bold>b</bold>) 4-OHT activates Cre recombinase (Cre) comprising two mutated estrogen receptor (ER) binding regions of CAG-ER<sup>T2</sup>CreER<sup>T2</sup> vector. Mir30-based shRNAs to DISC1 and HA-tagged RNAi-resistant DISC1 are expressed under control of the CAG promoter in the presence of 4-OHT-activated Cre (CALSL-DISC1 RNAi and CALNL-HA-DISC1<sup>R</sup>). (<bold>c</bold>) Three-electrode configuration for <italic>in utero</italic> electroporation to target the bilateral PFC. By using the custom-made electrode (upper panels), CALNL-GFP was simultaneously electroporated into the right and left side of PFC at embryonic day 14.5 (E14.5) and GFP expression was confirmed in the bilateral PFC at postnatal day 7 (P7) (lower panels). Scale bar, 1 mm. (<bold>d</bold>) Inducible DISC1 RNAi or Control RNAi were co-introduced with CAG-ER<sup>T2</sup>CreER<sup>T2</sup> and CALNL-GFP in the PFC at E14.5 followed by intraperitoneal injection of 4-OHT at P2. Efficient suppression of DISC1 immunoreactivity (red traced by dotted white lines) in GFP-positive pyramidal neurons (green) is shown in the medial PFC at P7. n = 30 neurons from three mice per condition. Scale bar, 10 µm. (<bold>e, f</bold>) Mice with postnatal knockdown of DISC1 in pyramidal neurons of the medial PFC show impaired dendritic development, but not radial neuronal migration. Total number of dendrites and dendrite branches in each category (primary, secondary, and tertiary of apical and basal dendrites) was analyzed at P7. DISC1 RNAi has a stronger effect than RNAi-2. Inducible co-expression with RNAi-resistant DISC1 (red) normalized dendritic abnormalities induced by knockdown of DISC1. In each condition, 10 neurons from independent brain slices were analyzed in a blinded manner. Traced dendrites were categorized as primary apical (yellow) and basal (red), secondary apical (blue) and basal (cyan) dendrites, as well as tertiary apical (green) and basal (yellow) dendrites, respectively. Only neurons with typical morphological characteristics of pyramidal neurons (single thick axon arising from the basal side of the soma with multiple basal dendrites and apical dendrites extending vertically to layer I) were analyzed. Green, GFP; blue, nucleus. Scale bar, 100 µm (upper panels), 20 µm (middle panels). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001 determined by Student’s <italic>t</italic> test (<bold>d</bold>) and one-way ANOVA with posthoc Bonferroni test (<bold>f</bold>).</p>
</caption>
<graphic xlink:href="nihms736995f2"></graphic>
</fig>
<fig id="F3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p id="P29">Postnatal suppression of DISC1 expression in the prefrontal cortex (PFC) impairs developmental synaptic GABA function. (<bold>a</bold>) Immunohistochemical analysis with antibodies against GABA<sub>A</sub> receptor α2 subunits (red) and gephyrin, a GABA synaptic scaffold protein (green), in developing pyramidal neurons (blue) of the medial PFC in mice with postnatal knockdown of DISC1 at P14. Reduction of colocalization of GABA<sub>A</sub> receptor α2 subunits and gephyrin are observed in postnatal DISC1 knockdown mice. Scale bar, 10 µm. n = 5 neurons per condition. (<bold>b</bold>) Immunohistochemical analysis with antibodies against vesicular GABA transporter (vGAT, a presynaptic marker, indicated in red) and gephyrin (a GABA synaptic scaffold protein, indicated in green), in the developing pyramidal neurons (blue) of the medial PFC in mice with postnatal knockdown of DISC1 and control mice at P14. No changes in the number of gephyrin puncta and colocalization of vGAT and gephyrin are observed in postnatal DISC1 knockdown mice compared to control mice. Scale bar, 10 µm. n=5 neurons per condition. (<bold>c, d</bold>) Acute brain slice electrophysiology recordings from P14 mice show that postnatal suppression of DISC1 depresses GABAergic transmission. Representative traces depicting GABA-mediated miniature postsynaptic currents (GABA-mediated mPSCs) from each condition are shown. Summary graphs showing the amplitude of GABA-mediated mPSCs are decreased by postnatal DISC1 suppression, while DISC1 suppression does not affect on mPSCs frequency. All recordings were performed in the presence of D,L AP5 (100 µM), NBQX (10 µM), and TTX (1 µM). n = 10–15 neurons per condition. *<italic>P</italic> &lt; 0.05 determined by Student’s <italic>t</italic> test (<bold>a, d</bold>).</p>
</caption>
<graphic xlink:href="nihms736995f3"></graphic>
</fig>
<fig id="F4" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p id="P30">Postnatal suppression of DISC1 expression in the prefrontal cortex (PFC) causes deficits in sensorimotor gating in young adulthood. (<bold>a</bold>) Postnatal knockdown of DISC1 in the PFC has no effect on locomotion as indicated by the open field test. (<bold>b</bold>) Postnatal suppression of DISC1 expression in the PFC has no effect on anxiety as indicated by the elevated plus maze test. (<bold>c</bold>) In the novel object recognition test, there were no differences in exploratory preference during training and retention sessions (left graph), and no abnormality in spatial recognition memory in postnatal DISC1 knockdown mice (right graph). (<bold>d</bold>) Excess acoustic startle response was observed in inducible DISC1 knockdown mice. n = 12 per condition. (<bold>e</bold>) Impairment of prepulse inhibition in the postnatal DISC1 suppression mice, when the 120 dB pulse was preceded by prepulses of 74, 78, and 82 dB. There were significant effects of genotype (F<sub>(1,110)</sub> = 53.92, <italic>P</italic> &lt; 0.0001), prepulse intensity (F<sub>(4,110)</sub> = 29.93, <italic>P</italic> &lt; 0.0001), and genotype-prepulse interaction (F<sub>(4,110)</sub> = 3.15, <italic>P</italic> = 0.0172). n = 12 per condition. (<bold>f</bold>) Projections from the PFC to nucleus accumbens core (NAc core), nucleus accumbens shell (NAc shell), and basolateral amygdala (BLA) were visualized by immunohistochemistry with antibodies against GFP (green). Postnatal DISC1 knockdown induced reductions in elevation of c-Fos expression (red) in the BLA, but not in the NAc core and NAc shell, following PPI. Blue, nucleus. Scale bar, 100 µm. n = 10 per condition. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001 determined by Student’s <italic>t</italic> test (<bold>d, f</bold>) and two-way repeated measures ANOVA followed by the Bonferroni test (<bold>e</bold>).</p>
</caption>
<graphic xlink:href="nihms736995f4"></graphic>
</fig>
<fig id="F5" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p id="P31">Subtype-selective positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors reverse dendritic abnormalities and altered behaviors induced by knockdown of DISC1. (<bold>a</bold>) Representative images showing effect of co-expressing RNAi-resistant DISC1 (DISC1<sup>R</sup>), and 7-day treatment with positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptors, AZD7325 (0.1 µM) and AZD6280 (0.1 µM), in primary cortical neuron expressing DISC1 RNAi carrying GFP protein (green). Traced dendrites were depicted as white lines (lower panels). Blue, nucleus. Scale bar, 100 µm. (<bold>b</bold>) Quantification of dendritic morphometry demonstrates that reduction of dendrite growth and branches as well as altered dendrite complexity induced by knockdown of DISC1 was ameliorated by co-expression with RNAi-resistant DISC1, in which the effect is comparable to treatment with AZD7325 and AZD6280. We analyzed only neurons with typical morphological characteristics of pyramidal neurons (single axon and multiple dendrites). n = 7 per condition. (<bold>c</bold>) Representative image showing dendritic structure of GFP-labeled pyramidal neurons in medial PFC from postnatal DISC1 suppression mice after intraperitoneal injection of AZD7325 (10 µmol/kg body weight) or vehicle for 1 week in the early postnatal period. Ratio of GFP fluorescence intensity in dendrites to total GFP fluorescence intensity was increased in AZD7325-treated inducible DISC1 knockdown mice, compared to those of vehicle-treated ones. Blue, nucleus. Scale bar, 100 µm. Ten brain slice images per condition were analyzed in a blinded manner. (<bold>d</bold>) Startle response to 120dB acoustic pulse was increased in the postnatal DISC1 knockdown mice compared to the control mice, and this excessive response was normalized by early postnatal treatment with AZD7325. (<bold>e</bold>) Impairment of prepulse inhibition in the postnatal DISC1 knockdown mice was rescued by AZD7325 treatment, significantly ameliorated at 74dB prepulse, and partially ameliorated at 78dB. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, and ***<italic>P</italic> &lt; 0.001 determined by one-way ANOVA with posthoc Bonferroni test (<bold>b, c, d, e</bold>).</p>
</caption>
<graphic xlink:href="nihms736995f5"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>